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We describe the deposition of four datasets consisting of X-ray diffraction images acquired using serial
femtosecond crystallography experiments on microcrystals of human G protein-coupled receptors, grown
and delivered in lipidic cubic phase, at the Linac Coherent Light Source. The receptors are: the human
serotonin receptor 2B in complex with an agonist ergotamine, the human δ-opioid receptor in complex with
a bi-functional peptide ligand DIPP-NH2, the human smoothened receptor in complex with an antagonist
cyclopamine, and finally the human angiotensin II type 1 receptor in complex with the selective antagonist
ZD7155. All four datasets have been deposited, with minimal processing, in an HDF5-based file format,
which can be used directly for crystallographic processing with CrystFEL or other software. We have
provided processing scripts and supporting files for recent versions of CrystFEL, which can be used to
validate the data.
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Background & Summary
Over the last few years, two X-ray free-electron laser (XFEL) facilities, the Linac Coherent Light Source
(LCLS) and the SPring-8 Ångstrom Compact free-electron Laser (SACLA), have been put to extensive
use in studying biological systems. The intense X-ray pulses outrun the conventional processes of
radiation-induced damage, allowing diffraction data to be recorded from micron-sized crystals, while at
the same time applying radiation doses far in excess of what would normally be considered tolerable in
macromolecular X-ray crystallography using a laboratory or synchrotron source, even at cryogenic
temperatures1,2. In turn, this allows data to be collected at near room temperature. Structure
determination of G-protein-coupled receptors (GPCRs) represents a particularly successful application of
serial femtosecond crystallography (SFX) at XFELs3–6. An injection device for viscous media4 has been
recently developed, which allows microcrystals to be delivered to the X-ray beam in the lipidic cubic
phase (LCP) medium in which they were grown, greatly simplifying the diffraction experiment by
circumventing the need to extract and mount crystals.
This paper reports the deposition of four SFX datasets acquired from GPCRs using LCP-SFX (Fig. 1).
The first dataset of the serotonin receptor 2B (5-HT2B) in complex with ergotamine was used to introduce
the LCP-SFX technique3. In the original publication, a comparison was made between electron densities
obtained by LCP-SFX at room temperature and conventional crystallography at cryogenic temperature
using a synchrotron radiation source. This comparison showed small differences between the structures,
attributed mostly to cryo-cooling, illustrating the importance of room temperature data collection. The
second dataset of the smoothened receptor (SMO) in complex with cyclopamine was collected as part of an
initial demonstration of the LCP injection technology4. SMO is involved in embryonal and stem cell
development, and therefore considered as a promising anti-tumour target. The third dataset was for the
δ-opioid receptor (δ-OR) in complex with a bifunctional peptide ligand DIPP-NH2, which acts as an
agonist at μ-opioid and as an antagonist at δ-opioid receptors5. Such bi-functional ligands show promise as
powerful analgesics with reduced propensity to inducing tolerance and dependency. The final dataset is of
the angiotensin II type 1 receptor (AT1R) in complex with the selective antagonist ZD7155 (ref. 6). AT1R is
a primary regulator of blood pressure in the human body and the target for treating hypertension.
Methods
The preparation of samples, data acquisition and processing for all four GPCRs have been described
previously3–6. GPCR microcrystals were prepared using the following general protocols, and specific
details, and small deviations from these protocols are noted under particular target receptor
sections below.
All engineered for crystallization GPCR constructs (Table 1) were cloned into a modified pFastBac
vector (Invitrogen) cassette containing the necessary tags, and expressed in Spodoptera frugiperda
(Sf9) insect cells for 48 h at 27 °C using recombinant baculovirus at a MOI (multiplicity of infection) of 5.
Cells were lysed by osmotic pressure and total membranes were isolated and purified by repeated
Figure 1. Schematic diagram of an LCP-SFX experiment. The stream of crystal-containing LCP is extruded
from the LCP injector into the focus of the X-ray beam, formed by upstream optics (Kirkpatrick-Baez mirrors
in this case). The LCP stream is kept straight by a coaxially flowing gas stream, indicated by the curved blue
dashed lines. The X-ray beam is represented by the orange cylinder. Diffracted X-rays are measured by the
detector (far left). The unscattered X-ray beam passes through a hole in the center of the detector. The LCP
injector and CSPAD detector are located inside a sample vacuum chamber (dotted line). Adapted from (ref. 3).
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Dounce homogenization and centrifugation in hypotonic and hypertonic buffers. GPCR-ligand
complexes were subsequently formed by incubating purified membranes in the presence of the
respective ligand, iodoacetamide and EDTA-free protease inhibitor cocktail, followed by extraction of the
complexes in N-dodecyl-β-D-maltopyranoside (DDM, Anatrace) and cholesteryl hemisuccinate (CHS,
Sigma) mixture. Solubilized receptors were purified by immobilized metal affinity chromatography
(IMAC) using TALON (Clontech) resin and concentrated to ~20–50 mgml−1. Crystallization was
performed in Hamilton gas-tight syringes as previously described7. Briefly, purified receptors were
first reconstituted in LCP by mixing protein solution with monoolein doped with 10% w/w cholesterol at
a 2:3 (v/v) ratio using a syringe mixer. Approximately 5 μl of protein-laden LCP were carefully injected as
a continuous column ~400 μm in diameter into each 100 μl Hamilton syringe filled with 60 μl of the
corresponding precipitant solution (Table 2) and incubated at 20 °C until crystals formed. Just prior to
starting data collection, samples from several syringes were consolidated together, the excess precipitant
solution was carefully removed, followed by the addition of ~25% v/v of 7.9 MAG to absorb the residual
precipitant solution. The crystal samples were characterized on site at LCLS by optical and UV
fluorescence imaging as well as by SONICC8.
Diffraction patterns (Fig. 2) were acquired at the Coherent X-ray Imaging (CXI) endstation at LCLS
using a lipidic cubic phase injector with 50 μm nozzle operating at a flow rate of 150–200 nl min−1 (ref. 4).
X-rays were focused using Kirkpatrick-Baez mirrors to create a focal spot of about 1.5 μm diameter, with
wavelengths as stated below. The diffraction patterns were recorded on a Cornell-SLAC Pixel Array
Detector (CSPAD)9,10. The detector data, as well as data from a wide range of other detectors such as
X-ray pulse energy monitors and electron bunch measurements (used to calculate the wavelength of each
X-ray pulse, which varied by a small amount due to the Self-Amplified Spontaneous Emission (SASE)
process of the LCLS), were all stored by the LCLS data acquisition system in Extensible Tagged Container
(XTC) files11. These files are extremely large because they contain all readouts from every X-ray pulse,
regardless of whether or not the X-ray pulse hit a crystal. Most pulses did not hit crystals, as shown by the
‘hit rates’ in Table 3. For further processing, we used Cheetah12 to identify ‘hits’ (images containing a
pre-set minimal number of Bragg reflections) and assembled the detector data, after minimal detector
corrections, to HDF5 files13. Relevant information such as the X-ray wavelengths, pulse energies and
timestamps, was also written to the HDF5 files. The HDF5 files have been deposited to the Coherent
X-ray Imaging Data Bank (CXIDB). The differences in processing parameters for Cheetah are
summarised in Table 4. The differences are in most cases unimportant to the interpretation of the data
and represent historical developments in Cheetah (for example, the change to a radial method of
background subtraction). For δ-OR and AT1R, the peak search area was restricted to avoid artefacts
visible near the edges of the detector.
Serotonin receptor, 5-HT2B
Purified membranes from Sf9 cells that expressed engineered 5-HT2B receptor (Table 1) were incubated
in the presence of 100 μM Ergotamine for 1 h at room temperature (21–23 °C). Extraction of the
complexes was done using 1% (w/v) DDM/0.2% (w/v) CHS. At the final purification stage, the sample
buffer was exchanged into 50 mM HEPES pH 7.5, 150 mM NaCl, 0.05% (w/v) DDM, 0.01% (w/v) CHS,
Receptor/ligand N-term tags N-term truncations C-term tags C-term truncations Mutations Fusion partner
5-HT2B/ergotamine HA-Flag 1–35 PP-10 × His 406–481 M144W BRIL in ICL3 (T249 to V313)
SMO/cyclopamine HA-Flag-10 × His-TEV CRD (1–189) None 556–787 None BRIL in ICL3 (P434 to K440)
δ-OR/DIPP-NH2 HA-Flag-10 × His-TEV 1–38 None 339–372 None N-term BRIL
AT1R/ZD7155 HA-Flag-10 × His-TEV 1, 7–16 None 320–359 None N-term BRIL
Table 1. Summary of the receptor constructs used for structure determination. 10 × His, 10-mer His tag;
BRIL, thermostabilized apocytochrome b562RIL from Escherichia coli (M7W, H102I and R106L); C-term,
C terminal; CRD, cysteine-rich domain; Flag, flag tag; HA, hemagglutinin signal sequence; ICL3, intracellular
loop 3; N-term, N terminal; PP, prescission protease-recognition site; TEV, TEV protease-recognition site.
Receptor/ligand Buffer Precipitant Salt Additive
5-HT2B/ergotamine 0.1 M Tris pH 8.0 30% v/v PEG 400 20–80 mM MgCl2
SMO/cyclopamine 0.1 M Hepes pH 7.0 30% v/v PEG 400 100 mM NaCl
δ-OR/DIPP-NH2 0.1M MES pH 6.0 30-32% v/v PEG 400 50–180 mM Li citrate
AT1R/ZD7155 0.1M Na Citrate pH 5.0 28% v/v PEG 400 450 mM NH4H2PO4 4% v/v DMSO
Table 2. Summary of crystallization conditions.
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10% (v/v) glycerol, and 50 μM ergotamine, and the protein was concentrated to ~ 20 mgml−1.
Microcrystals with an average size of 5 × 5 × 5 μm were obtained in syringes within 24 h at 20 °C and
used for SFX data collection.
The X-ray wavelength for data acquisition was 1.3 Å (photon energy 9.5 keV) and data were acquired
at sample-detector distances of 82, 112 and 152 mm (the majority). The 5-HT2B data collection was
performed during LCLS experiment L672 in March 2013.
Data from LCLS in facility XTC format were processed using Cheetah. A total of 4,217,508 detector
frames were processed, from which Cheetah found 152,531 crystal hits (Table 4). The detector distance
was read from EPICS process variable CXI:DS1:MMS:06.RBV. Frames corresponding to a hit were saved
to individual HDF5 data files with only detector corrections applied (in this case dark offset subtraction
Figure 2. Representative diffraction patterns from (a) 5-HT2B, (b) AT1R, (c) SMO and (d) δ-OR. The solid
grey areas are the regions outside the panels of the detector. The diffuse circle arises from the LCP matrix, and
sharp spots from the crystals. Pattern (d) is shown with calculated reflection positions circled, but (a–c) are not.
Receptor/ligand Data
citation
CXIDB accession
number
PDB accession code for
XFEL structure
Acquisition dates Number of frames
acquired
Number of hits found
(overall hit rate)
5-HT2B/ergotamine 1 21 4NC3 20–24 March 2013 4,217,508 152,531 (3.6%)
SMO/cyclopamine 2 39 4O9R 20–24 March 2013 3,510,525 274,214 (7.8%)
δ-OR/DIPP-NH2 3 40 4RWD 2–3 Feb 2014 1,967,539 125,458 (5.9%)
AT1R/ZD7155 4 38 4YAY 31 Jan-2 Feb 2014 2,764,739 457,275 (17%)
Table 3. Basic information about the four datasets.
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and a per-pixel gain correction derived from flat field data). Processing parameters and calibration files
are archived with the deposited data for reference.
Our new indexing and integration with CrystFEL 0.6.2 was performed using the same parameters as
for the original processing, as follows: peak search mode ‘zaef’ with threshold 450, minimum squared
gradient 500 and minimum SNR (signal-to-noise) 4. Indexing was performed with Mosflm 7.2.0
(using prior unit cell parameters and lattice type information), followed by DirAx, and finally Mosflm
without any prior information as a final fallback. The target unit cell was primitive orthorhombic with
a= 61.7 Å, b= 122.8 Å and c= 168.1 Å. Indexing solutions were accepted if the reciprocal cell axis lengths
and angles matched within 4% of the target lengths and 1.4° of the target angles respectively. Reflections
were integrated using shoebox summation integration with an inner radius of 3 pixels and a background
annulus between 7 and 8 pixels centred on each calculated reflection position.
Smoothened receptor
Purified membranes from Sf9 cells that expressed engineered SMO (Table 1) were incubated for 1 h at
4 °C in the presence of 50 μM of antagonist cyclopamine, followed by extraction of the receptor/ligand
complexes in 1% (w/v) DDM and 0.2% (w/v) CHS. The protein was eluted in a buffer containing 50 mM
HEPES, pH 7.5, 300 mM NaCl, 10% (v/v) glycerol, 0.03% (w/v) DDM, 0.006% (w/v) CHS, 250 mM
imidazole and 50 μM ligand and concentrated to 50mgml−1 for crystallization. Microcrystals with
maximal size less than 5 μm were obtained in syringes and used for SFX data collection.
The X-ray wavelength for data acquisition was 1.3 Å (photon energy 9.5 keV) and data were acquired
at sample-detector distances of 121 and 151 mm (the majority). The SMO data collection was performed
during LCLS experiment L672 in March 2013.
Data from LCLS in facility XTC format were processed using Cheetah. A total of 3,510,525 detector
frames were processed, from which Cheetah found 274,214 crystal hits (Table 4). The detector distance
was read from EPICS process variable CXI:DS1:MMS:06.RBV. Frames corresponding to a hit were saved
to individual HDF5 data files with only detector corrections applied (in this case dark offset subtraction
and a per-pixel gain correction derived from flat field data). Processing parameters and calibration files
are archived with the deposited data for reference.
Our new indexing and integration using CrystFEL 0.6.2 was performed using the same parameters as
for the previous processing, as follows: peak search mode ‘zaef’ with threshold 600, minimum squared
gradient 3,000 and minimum SNR 6. Indexing was performed with Mosflm 7.2.0 (using prior unit cell
parameters and lattice type information), followed by DirAx, and finally Mosflm without any prior
information as a final fallback. The target unit cell was primitive monoclinic with a= 40.5 Å, b= 157.3 Å,
c= 52.4 Å and β= 97°. Indexing solutions were accepted if the reciprocal cell axis lengths and angles
matched within 7% of the target lengths and 6° of the target angles respectively. Reflections were
integrated using shoebox summation integration with an inner radius of 3 pixels and a background
annulus between 4 and 5 pixels centred on each calculated reflection position.
Delta-opioid receptor
Purified membranes from Sf9 cells that expressed engineered δ-OR (Table 1) were incubated for 1 h at
4 °C in the presence of 50 μM of bi-functional peptide ligand DIPP-NH2, followed by extraction of
receptor/ligand complexes in 0.75% (w/v) DDM/0.15% (w/v) CHS and purification using IMAC. After
purification the protein was treated overnight with histidine-tagged TEV protease to cleave the
N-terminal histidine tag and Flag tag. TEV protease and the cleaved N-terminal fragment were removed
by incubation with TALON resin for 1 h at 4 °C. Purified receptor in 50 mM HEPES, pH 7.5, 500 mM
NaCl, 10% (v/v) glycerol, 0.03% (w/v) DDM, 0.006% (w/v) CHS and 50mM DIPP-NH2 was concentrated
to 40 mgml−1. Purified δ-OR-DIPP-NH2 complex was reconstituted in LCP as described above.
Microcrystals with average size of 5 × 2 × 2 μm were obtained in syringes and used for SFX data collection.
The X-ray wavelength for data acquisition was 1.6 Å (photon energy 7.95 keV) and data were acquired
at sample-detector distances of 78.8 mm (the majority) and 109 mm. The δ-OR data collection was
performed during LCLS experiment LA25 in January 2014.
Data from LCLS in facility XTC format were processed using Cheetah. A total of 1,967,539 detector
frames were processed, from which Cheetah found 125,458 crystal hits (Table 4). Frames corresponding
Receptor/ligand Minimum number of
peaks
Peak criteria Peak search radii
(pixels)
Cheetah peakfinder
algorithm
Background subtraction for
peak search
5-HT2B/ergotamine 15 2–20 pixels above 180 ADU 75–3,000 3 Median filter, 3 pixels radius
SMO/cyclopamine 15 2–20 pixels above 180 ADU 75–3,000 3 Median filter, 2 pixels radius
δ-OR/DIPP-NH2 15 2–40 pixels above 40 ADU
with SNR above 4
70–700 8 Radial background subtraction
AT1R/ZD7155 15 2–40 pixels above 40 ADU
with SNR above 4
70–700 8 Radial background subtraction
Table 4. Parameters for hit finding using Cheetah.
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to a hit were saved to individual HDF5 data files with only detector corrections applied (in this case
only dark offset subtraction). Processing parameters and calibration files are archived with the deposited
data for reference.
Our new indexing and integration using CrystFEL 0.6.2 was performed using the same parameters as
for the previous processing, as follows: the Bragg peaks found by Cheetah during the hit-finding stage
were used for indexing with Mosflm 7.2.0 (using prior unit cell parameters and lattice type information),
followed by DirAx, and finally Mosflm without any prior information as a final fallback. The target unit
cell was monoclinic C with a= 156.23 Å, b= 89.29 Å, c= 96.42 Å and β= 92.3°. Indexing solutions were
accepted if the reciprocal cell axis lengths and angles matched within 5% of the target lengths and 1.5° of
the target angles respectively (the default values in CrystFEL 0.6.2). Reflections were integrated using
shoebox summation integration with an inner radius of 3 pixels and a background annulus between 4 and
5 pixels centred on each calculated reflection position.
Figure 3. Plots of the self-consistency figures of merit (a) Rsplit and (b) CC1/2 against resolution for all four
datasets as re-processed here.
Receptor/ligand Peak search
method
Peak search
parameters
Unit cell
tolerance
Peak integration
radius (pixels)
Radii of background
annulus (pixels)
Per-crystal resolution
cutoff
5-HT2B/
ergotamine
CrystFEL
internal (‘zaef’)
Threshold 450, min
grad 500, SNR 4
4%, 1.4° 3 7–8 No cutoff
SMO/
cyclopamine
CrystFEL
internal (‘zaef’)
Threshold 600, min
grad 3000, SNR 6
7%, 6° 3 4–5 No cutoff
δ-OR/DIPP-NH2 Peaks from
Cheetah
See Table 4 5%, 1.5° 3 4–5 1.0 nm−1 above conservative
resolution estimate
AT1R/ZD7155 Peaks from
Cheetah
See Table 4 5%, 1.5° 3 4–5 1.0 nm−1 above conservative
resolution estimate
Table 5. Parameters for data processing using CrystFEL.
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Angiotensin receptor
Purified membranes from Sf9 cells that expressed engineered AT1R (Table 1) were incubated for 1 h at
4 °C in the presence of 100 μM of the antagonist ZD7155, followed by extraction of the receptor/ligand
complexes in 1% (w/v) DDM/0.2% (w/v) CHS. After purification by IMAC the receptor sample was
desalted to remove imidazole using PD MiniTrap G-25 column (GE Healthcare) and then treated
overnight with His-tagged TEV protease to cleave the N-terminal FLAG/His tags from the protein.
The cleaved FLAG/His tags and TEV protease were removed by incubation with TALON resin. The
protein was not treated with PNGase F and therefore remained fully glycosylated. Finally, the purified
protein was concentrated to 30 mgml−1 and used for crystallization. Microcrystals with an average size of
10 × 2 × 2 μm were obtained in gas-tight Hamilton syringes and used for SFX data collection.
The X-ray wavelength for data acquisition was 1.6 Å (photon energy 7.95 keV) and the
sample-detector distance was 108 mm. The AT1R data collection was performed during LCLS
experiment LA25 in January 2014.
Data from LCLS in facility XTC format were processed using Cheetah. A total of 2,764,739 detector
frames were processed, from which Cheetah found 457,275 crystal hits (Table 4). Frames corresponding
to a hit were saved to individual HDF5 data files with only detector corrections applied (in this case
only dark offset subtraction). Processing parameters and calibration files are archived with the deposited
data for reference.
Our new indexing and integration using CrystFEL 0.6.2 was performed using the same parameters as
for the previous processing, as follows: the peaks found by Cheetah during the hit-finding stage were used
for indexing with Mosflm 7.2.0 (using prior unit cell parameters and lattice type information), followed
by DirAx, and finally Mosflm without any prior information as a final fallback. The target unit cell was
monoclinic C with a= 72.8 Å, b= 41.0 Å, c= 167.7 Å and β= 99.4°. Indexing solutions were accepted if
the reciprocal cell axis lengths and angles matched within 5% of the target lengths and 1.5° of the target
angles respectively (the default values in CrystFEL 0.6.2). Reflections were integrated using shoebox
summation integration with an inner radius of 3 pixels and a background annulus between 4 and 5 pixels
centred on each calculated reflection position.
Code availability
The hit-finding and processing program Cheetah is free and open source software distributed under the
GNU General Public Licence version 3 (GPL3), and may be downloaded from the following web location:
https://www.desy.de/~barty/cheetah.
Data Records
We have deposited four datasets, one for each of the receptors: 5-HT2B (Data Citation 1), SMO
(Data Citation 2), δ-OR (Data Citation 3) and AT1R (Data Citation 4), as shown in Table 3. Out of the
millions of frames acquired, each dataset consists of the ‘hits’, where the X-ray pulse intersected a crystal
and gave rise to Bragg peaks as determined by Cheetah (Fig. 2). This reduces the volume of data by a
factor of about 20, to a level, which is practical for download and processing, while retaining practically
all of the useful information. Only minimal detector corrections have been applied, namely the
subtraction of detector ‘dark’ signal determined using frames acquired just before or after with the X-ray
beam shutter closed, and a per-pixel gain correction for 5-HT2B and SMO.
The datasets have been deposited in a format based on the Hierarchical Data Format, version 5
(HDF5). HDF5 is a ‘container format’ which has some of the properties of a file system, allowing
arbitrary numbers of arrays, each of arbitrary dimensionality, to be contained in ‘groups’ which behave
like directories and can be nested to form a tree structure. This format allows the image data to be stored
Figure 4. Plots of the signal-to-noise ratio I/sigma(I) for all four datasets as reprocessed here.
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alongside the X-ray photon energy (as estimated from the electron beam and undulator parameters),
pulse energy, motor positions relating to the sample-detector distance, and so on. HDF5 makes the data
‘self-describing’ as far as the identification of datasets is concerned, for example the photon energy is
found at ‘/LCLS/photon_energy_eV’ and the image data itself at ‘/data/rawdata’. This makes the data very
much easier to handle compared to the raw data format output by the LCLS data acquisition system,
which is an ‘XTC’ (Extensible Tagged Container) file containing readouts from all detectors and sensors,
and cannot easily be interpreted without using facility-specific software which is not supported for use
outside the LCLS computing environment. Nevertheless, some extra information is required to map the
pixel coordinates into physical space and hence interpret the data. We have provided this information in
the form of CrystFEL geometry files. The syntax of CrystFEL geometry files is described fully in the
CrystFEL documentation.
Technical Validation
All four datasets have previously been indexed, integrated and merged using CrystFEL, a software suite
created specifically for processing serial crystallography data14. The resulting merged data have been
used to solve the structures of the corresponding receptor complexes by molecular replacement, as
previously described3–6. To validate the data, we have repeated the indexing, integration and merging
stages using the latest version of CrystFEL, version 0.6.2. We did not further refine the detector
geometry, but rather used the previous detector geometry files after a small amount of conversion to
render them compatible with the latest version of CrystFEL. Merging was performed using partialator
from CrystFEL, without partiality modelling (partialator's ‘unity’ model), three iterations of scaling
and merging, excluding reflections with any pixel intensity exceeding 14,000 detector units.
The intensities were merged according to point group mmm for 5-HT2B and 2/m (unique axis b)
for AT1R, δ-OR and SMO. The default values were used for all other parameters. Per-pattern resolution
cutoffs, in which intensities were merged up to 1 nm−1 above the resolution estimate based on
the limit of the found peaks, were used for two of the data sets (δ-OR and AT1R) but not the others.
The CrystFEL processing parameters for the updated results are summarised in Table 5. The differences
in peak search methods are simply because more recent versions of Cheetah were used for two of the
data sets (δ-OR and AT1R), and the more recent versions are able to find peaks more effectively
than CrystFEL's internal algorithm. Differences in peak search parameters are because of differences in
the scattering strength of the crystals and background levels. The unit cell parameter tolerances must be
wide enough to capture all the indexing solutions which match the target parameters, while excluding
other indexing solutions. In practice, a rather generous tolerance can safely be used for this, as was the
case for SMO.
We calculated the usual figures of merit for SFX data (Rsplit, CC* and I/sigma(I)) over the same
resolution ranges used for the original publications (Figs 3 and 4). Although we have not repeated the full
structure determination, the figures of merit calculated during processing the data are almost all
better than the previously published results, even despite a lower number of indexed patterns used in two
of the cases. The lower number of indexed patterns is most likely due to the additional processing stages,
which have been added in recent versions of CrystFEL. These new processing routines impose additional
restrictions on the quality of the data resulting in rejection of some patterns15. The figures of merit are
shown in Table 6.
Usage Notes
The deposited data can be processed directly using CrystFEL. For each dataset, we have deposited a script,
called ‘run-processing’, which contains short series of commands necessary to index, integrate and merge
the data, and to produce the figures of merit shown in Table 6. In addition, we have deposited an archive
of CrystFEL 0.6.2 in source code form with each dataset.
Receptor/
ligand
Number of
crystals found
Number of crystals
merged
Resolution
range, Å
Rsplit, % CC
* I/sigI
5-HT2B/
ergotamine
20,589 [32,819] 17,860 [32,819] 35–2.8
(2.9–2.8)
6.71 (116) [9.5 (162)]] 0.9990 (0.773) [0.998 (0.74)] 6.73 (0.99) [5.9 (0.64)]
SMO/
cyclopamine
42,640 [61,964] 42,198 [61,964] 40–3.2
(3.3–3.2)
8.94 (385) [9.8 (63.2)] 0.9995 (0.7004) [0.9991 (0.28)] 6.20 (0.34) [7.4 (1.8)]
δ-OR/DIPP-
NH2
70,899 [36,083] 70,767 [36,083] 33.5–2.7
(2.8–2.7)
11.9 (121) [11.8 (87.9)] 0.9980 (0.7053) [Not reported] 6.63 (0.989) [6.0 (1.3)]
AT1R/
ZD7155
79,558 [73,130] 77,282 [71,130] 32.6–2.9
(3.0–2.9)
8.60 (209) [9.8 (140)] 0.9990 (0.7587) [0.999 (0.872)] 7.60 (0.55) [8.2 (0.84)]
Table 6. Crystallographic statistics of the four datasets from re-processing using CrystFEL 0.6.2. Values in
parentheses are those for the highest resolution shell. Values in square brackets are those from the previously
reported processing using old CrystFEL versions.
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